「能纳入就纳入」:精神药理学试验中儿科患者入组率低的原因
本研究系统收集某随机双盲安慰剂对照试验的预筛患者资料,分析儿童青少年强迫症与孤独症谱系障碍患者未参与试验的原因。共预筛173例,仅5例(2.9%)最终入组,主要未纳入原因为不符合全部入组标准或符合排除标准、对试验无兴趣、不愿改变现有治疗。
要点
- 预筛173例患者中仅2.9%最终入组,入组率低。
- 主要未纳入原因为不符合入组标准或符合排除标准。
- 低入组与高排除率可能限制试验结果的外推性。
核心结论
- 儿童精神药理学试验入组率低且排除率高,可能影响研究人群的代表性与结果外推性。
研究设计与样本
- 研究为随机双盲安慰剂对照临床试验的一部分,系统收集预筛患者人口学资料及未参与原因,按内容分组并做描述性统计分析。
主要发现
- 共预筛173例患者,最终仅5例(2.9%)入组。
- 未纳入原因包括不符合全部入组标准或符合一项以上排除标准(73例,42.2%)。
- 未纳入原因包括对试验或试验总体无兴趣(40例,23.1%)。
- 未纳入原因包括不愿改变当前治疗或用药(14例,8.1%)。
临床怎么用
- 结果提示应改进招募策略,并关注试验人群代表性以提升儿童精神药理学试验的外部效度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Low recruitment in clinical trials is a common and costly problem which undermines medical research. This study aimed to investigate the challenges faced in recruiting children and adolescents with obsessive-compulsive disorder and autism spectrum disorder for a randomized, double-blind, placebo-controlled clinical trial and to analyze reasons for non-participation. The trial was part of the EU FP7 project TACTICS (Translational Adolescent and Childhood Therapeutic Interventions in Compulsive Syndromes). METHODS: Demographic data on pre-screening patients were collected systematically, including documented reasons for non-participation. Findings were grouped according to content, and descriptive statistical analyses of the data were performed. RESULTS: In total, n = 173 patients were pre-screened for potential participation in the clinical trial. Of these, only five (2.9%) were eventually enrolled. The main reasons for non-inclusion were as follows: failure to meet all inclusion criteria/meeting one or more of the exclusion criteria (n = 73; 42.2%), no interest in the trial or trials in general (n = 40; 23.1%), and not wanting changes to current therapy/medication (n = 14; 8.1%). CONCLUSIONS: The findings from this study add valuable information to the existing knowledge on reasons for low clinical trial recruitment rates in pediatric psychiatric populations. Low enrollment and high exclusion rates raise the question of whether such selective study populations are representative of clinical patient cohorts. Consequently, the generalizability of the results of such trials may be limited. The present findings will be useful in the development of improved recruitment strategies and may guide future research in establishing the measurement of representativeness to ensure enhanced external validity in psychopharmacological clinical trials in pediatric populations. TRIAL REGISTRATION: EudraCT 2014-003080-38 . Registered on 14 July 2014.
引用
- Niemeyer L, Mechler K, Buitelaar J, et al. "Include me if you can"-reasons for low enrollment of pediatric patients in a psychopharmacological trial. Trials. 2021. PMID: 33648579. doi:10.1186/s13063-021-05119-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。